ExploreWatchlistsPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Gross margin (%)

LTT Bio-Pharma Co., Ltd. (E00982)

Market cap
P/E ratio
LTT Biopharma develops new drugs using drug delivery and repositioning technologies, while helping Japanese and Chinese healthcare companies collaborate.
SummaryFinancialsDividendsHistoryWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202559.2-7.04%
Mar 31, 202463.7-36.05%
Mar 31, 202399.6+1.14%
Mar 31, 202298.5+117.03%
Mar 31, 202145.4-45.05%
Mar 31, 202082.6-17.42%
Mar 31, 2019100+2.79%
Mar 31, 201897.3+44.17%
Mar 31, 201767.5-13.30%
Mar 31, 201677.8-15.17%
Mar 31, 201591.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat